Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ecovyst (ECVT) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Ecovyst (ECVT) over the last 10 years, with Q3 2025 value amounting to $82.0 million.

  • Ecovyst's Cash & Equivalents fell 3360.87% to $82.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $82.0 million, marking a year-over-year decrease of 3360.87%. This contributed to the annual value of $131.4 million for FY2024, which is 4869.01% up from last year.
  • Ecovyst's Cash & Equivalents amounted to $82.0 million in Q3 2025, which was down 3360.87% from $69.6 million recorded in Q2 2025.
  • Over the past 5 years, Ecovyst's Cash & Equivalents peaked at $151.2 million during Q2 2022, and registered a low of $29.2 million during Q2 2023.
  • Its 5-year average for Cash & Equivalents is $91.5 million, with a median of $88.4 million in 2023.
  • In the last 5 years, Ecovyst's Cash & Equivalents crashed by 8067.02% in 2023 and then soared by 22224.34% in 2024.
  • Quarter analysis of 5 years shows Ecovyst's Cash & Equivalents stood at $104.8 million in 2021, then increased by 15.94% to $121.4 million in 2022, then dropped by 27.24% to $88.4 million in 2023, then surged by 48.69% to $131.4 million in 2024, then plummeted by 37.61% to $82.0 million in 2025.
  • Its Cash & Equivalents stands at $82.0 million for Q3 2025, versus $69.6 million for Q2 2025 and $127.5 million for Q1 2025.